Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Redei, E E ^a   Andrus, B M ^a   Kwasny, M J ^a   Seok, J ^a,b   Cai, X ^a   Ho, J ^a   Mohr, D C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE 3; BIOLOGICAL MARKER; CELL ADHESION MOLECULE 1; DIACYLGLYCEROL KINASE ALPHA; FAMILY WITH SEQUENCE SIMILARITY 46 MEMBER A PROTEIN; IMMUNOGLOBULIN SUPERFAMILY MEMBER 4 PROTEIN; KIAA1539 PROTEIN; MARCKS PROTEIN; PROTEASOME ACTIVATOR SUBUNIT 1; RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAIN 1 PROTEIN; RNA; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; ADENYLATE CYCLASE; CADM1 PROTEIN, HUMAN; CARRIER PROTEIN; CELL ADHESION MOLECULE; FAM46A PROTEIN, HUMAN; GENETIC MARKER; IMMUNOGLOBULIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; PROTEASOME; PROTEIN; PSME1 PROTEIN, HUMAN; RAPH1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TLR7 PROTEIN, HUMAN; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE TYPE 11C; CERAMIDASE; PROTEIN ADCY3; PROTEIN CADM1; PROTEIN DGKA; PROTEIN FAM46A; PROTEIN IGSF4A; PROTEIN KIAA1539; PROTEIN MARCKS; PROTEIN PSME1; PROTEIN RAPH1;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; COGNITIVE THERAPY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT HEALTH QUESTIONNAIRE 9; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; REMISSION; RNA TRANSCRIPTION; SELF REPORT; TRANSCRIPTOMICS; TREATMENT RESPONSE; BLOOD; DEPRESSIVE DISORDER, MAJOR; GENETIC MARKER; GENETICS; MIDDLE AGED; PRIMARY HEALTH CARE; AREA UNDER THE CURVE; BLOOD SAMPLING; CLINICAL ARTICLE; PATIENT HEALTH QUESTIONNAIRE; PERSONALIZED MEDICINE; RACE;

ADENYLATE CYCLASE; ADULT; CARRIER PROTEINS; CELL ADHESION MOLECULES; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; PRIMARY HEALTH CARE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; TOLL-LIKE RECEPTOR 7;

EID: 84907367946     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.66     Document Type: Article

References (52)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
2. Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord 2012; 140: 205-214.
3. Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7: 3-7.
4. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013; 10: e1001547.
5. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 2010; 122: 184-191.
6. ten Doesschate MC, Bockting CL, Koeter MW, Schene AH. Prediction of recurrence in recurrent depression: a 5.5-year prospective study. J Clin Psychiatry 2010; 71: 984-991.
7. Carter JD, Frampton CM, Mulder RT, Luty SE, Joyce PR. The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord 2010; 124: 202-206.
8. Riedel M, Moller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M et al. Response and remission criteria in major depression-A validation of current practice. J Psychiatr Res 2010; 44: 1063-1068.
9. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008; 358: 55-68.
10. Altamura AC, Buoli M, Albano A, Dell'Osso B. Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study. Int Clin Psychopharmacol 2010; 25: 172-179.
11. Huerta-Ramirez R, Bertsch J, Cabello M, Roca M, Haro JM, Ayuso-Mateos JL. Diagnosis delay in first episodes of major depression: a study of primary care patients in Spain. J Affect Disord 2013; 150: 1247-1250.
12. Pence BW, O'Donnell JK, Gaynes BN. The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep 2012; 14: 328-335.
13. Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ et al. Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 2012; 17: 49-61.
14. Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J et al. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry 2012; 2: e101.
15. Mohr DC, Ho J, Duffecy J, Reifler D, Sokol L, Burns MN et al. Effect of telephoneadministered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. JAMA 2012; 307: 2278-2285.
16. Mohr DC, Vella L, Hart SL, Heckman T, Simon GE. The effect of telephoneadministered psychotherapy on depression and attrition: a meta-Analysis. Clin Psych 2008; 15: 243-253.
17. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20): 22-33. quiz 34-57.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
19. Desmond DW, Tatemichi TK, Hanzawa L. The Telephone Interview for Cognitive Status (TICS): reliability and validity in a stroke sample. Int J Geriatr Psychiatry 1994; 9: 803-807.
20. MacArthur Foundation's Initiative on Depression and Primary Care. The MacArthur Initiative on Depression and Primary Care at Dartmouth and Duke: Depression Management Toolkit. Hanover, NH, USA: Dartmouth, 2004.
21. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate -A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 1995; 57: 289-300.
22. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
23. Team RC R: A language and environment for statistical computing. ISBN 3-900051-07-0. R Foundation for Statistical Computing. Vienna, Austria, 2013. Avaliable online at http://www.R-project.org; 2005.
24. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn, Hillsdale, NJ, USA: L Erlbaum Associates, 1988.
25. Pepe M, Longton G, Janes H. Estimation and Comparison of Receiver Operating Characteristic Curves. Stata J 2009; 9: 1.
26. Menke A. Gene expression: biomarker of antidepressant therapy? Int Rev Psychiatry 2013; 25: 579-591.
27. Mehta D, Menke A, Binder EB. Gene expression studies in major depression. Curr Psychiatry Rep 2010; 12: 135-144.
28. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006; 147: 126-132.
29. Rollins B, Martin MV, Morgan L, Vawter MP. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 919-936.
30. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 261-268.
31. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 2011; 16: 37-58.
32. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009; 14: 156-174.
33. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 2008; 65: 395-407.
34. Menke A, Arloth J, Putz B, Weber P, Klengel T, Mehta D et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 2012; 37: 1455-1464.
35. Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, Milwidsky A et al. Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry 2010; 15: 2.
36. Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, Zitman FG et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry 2010; 68: 179-186.
37. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH et al. Assessment of a multi-Assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 2013; 18: 332-339.
38. Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM et al. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-Analysis of three studies. Mol Psychiatry 2011; 16: 202-215.
39. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
40. Wray NR, Pergadia ML, Blackwood DHR, Penninx BWJH, Gordon SD, Nyholt DR et al. Genome-wide association study of major depressive disorder: new results, meta-Analysis, and lessons learned. Mol Psychiatry 2012; 17: 36-48.
41. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P. Unmasking diseasespecific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 2002; 159: 1830-1840.
42. Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry 2010; 67: 1256-1264.
43. Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Treziny C, Verrier L et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry 2012; 2: e185.
44. Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav 2014; 13: 13-24.
45. Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 2003; 100: 9608-9613.
46. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITEMD study. Psychiatry Res 2009; 169: 124-131.
47. Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-Analysis. J Affect Disord 2014, 159: 118-126.
48. Licinio J, Wong ML. Launching the 'war on mental illness'. Mol Psychiatry 2014; 19: 1-5.
49. Licinio J, Wong ML. Pharmacogenomics of antidepressant treatment effects. Dialogues Clin Neurosci 2011; 13: 63-71.
50. Radich JP, Mao M, Stepaniants S, Biery M, Castle J, Ward T et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004; 83: 980-988.
51. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 2005; 22: 402-411.
52. Mohr S, Liew C-C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007; 13: 422-432.